Supply Chain

Rx-360 Supply Chain Security White Paper: Incident Management Version 2.0

Rx-360 Supply Chain Security: Prevention of Re-use of Genuine Packaging Components for Counterfeit Products

FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)

Rx-360 Supply Chain Security: A Comprehensive Supply Chain Security Management System Version 2.0

Rx-360 Natural Disaster Contingency Planning

Taking a Collaborative Approach to Secure Donated Medicines

Rx-360 Quality Elements for Suppliers of Products or Services to GMP Regulated Companies

Standardization of Data and Documentation Practices for Product Tracing Guidance for Industry

Over Half Of U.S. States Have Now Seen Fatalities From Counterfeit Drugs Made With Fentanyl

FDA Alerts Drug Makers of a Recall of Porcine Thyroid API from Sichuan Friendly Pharmaceutical Co., Limited, China

Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan / Amlodipine / HCTZ Tablets

Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration

Chinese Vaccine Maker Made 500,000 Substandard Baby Vaccines: Xinhua

EMA Reviewing Medicines Containing Valsartan from Zhejiang Huahai Following Detection of an Impurity

EU Sees One in 5,000 Cancer Risk from Tainted China Heart Drug

China Heart Drug Sold Globally May Have Had Impurity Since 2012

FDA Updates on Valsartan Recalls

RECALL: Blood Pressure Medication, Valsartan, Recalled Due to Possible Contaminants

Definitions of Suspect Product & Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act Guidance

CDER Issues Planned Guidance Agenda for CY2018

FDA Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification

Cargo Theft in the Pharmaceutical Industry – What Does it Really Cost?

Upstream Supply Chain Mapping

Upstream Supply Chain Security Risk Assessment Tool

Supply Chain Mapping Spreadsheet

Upstream Supply Chain Security

Counterfeit, Unapproved and Diverted Drugs Threats & Monitoring Process